Secretion and Dipeptidyl Peptidase-4-Mediated Metabolism of Incretin Hormones after a Mixed Meal or Glucose Ingestion in Obese Compared to Lean, Nondiabetic Men
被引:115
作者:
Carr, Richard D.
论文数: 0引用数: 0
h-index: 0
机构:
Novo Nordisk AS, DK-2880 Bagsvaerd, DenmarkLund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, Sweden
Carr, Richard D.
[2
]
Larsen, Marianne O.
论文数: 0引用数: 0
h-index: 0
机构:
Novo Nordisk AS, DK-2880 Bagsvaerd, DenmarkLund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, Sweden
Larsen, Marianne O.
[2
]
Jelic, Katarina
论文数: 0引用数: 0
h-index: 0
机构:
Novo Nordisk AS, DK-2880 Bagsvaerd, DenmarkLund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, Sweden
Jelic, Katarina
[2
]
Lindgren, Ola
论文数: 0引用数: 0
h-index: 0
机构:
Lund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, SwedenLund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, Sweden
Lindgren, Ola
[1
]
Vikman, Jenny
论文数: 0引用数: 0
h-index: 0
机构:
Lund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, SwedenLund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, Sweden
Vikman, Jenny
[1
]
Holst, Jens J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen, DenmarkLund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, Sweden
Holst, Jens J.
[3
]
Deacon, Carolyn F.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen, DenmarkLund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, Sweden
Deacon, Carolyn F.
[3
]
Ahren, Bo
论文数: 0引用数: 0
h-index: 0
机构:
Lund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, SwedenLund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, Sweden
Ahren, Bo
[1
]
机构:
[1] Lund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, Sweden
Context: Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are cleaved by dipeptidyl peptidase-4 (DPP-4); plasma activity of DPP-4 may be increased in obesity. The impact of this increase on incretin hormone secretion and metabolism is not known. Objective: The aim of the study was to assess incretin hormone secretion and degradation in lean and obese nondiabetic subjects. Design, Settings, and Participants: We studied the ingestion of a mixed meal (560 kcal) or oral glucose (2 g/kg) in healthy lean (n = 12; body mass index, 20-25 kg/m(2)) or obese (n = 13; body mass index, 30-35 kg/m(2)) males at a University Clinical Research Unit. Main Outcome Measures: We measured the area under the curve of plasma intact (i) and total (t) GIP and GLP-1 after meal ingestion and oral glucose. Results: Plasma DPP-4 activity was higher in the obese subjects (38.5 +/- 3.0 vs. 26.7 +/- 1.6 mmol/min . mu l; P = 0.002). Although GIP secretion (AUC(tGIP)) was not reduced in obese subjects after meal ingestion or oral glucose, AUC(iGIP) was lower in obese subjects (8.5 +/- 0.6 vs. 12.7 +/- 0.9 nmol/liter X 300 min; P < 0.001) after meal ingestion. GLP-1 secretion (AUC(tGLP-1)) was reduced in obese subjects after both meal ingestion (7.3 +/- 0.9 vs. 10.0 +/- 0.6 nmol/liter X 300 min; P = 0.022) and oral glucose (6.6 +/- 0.8 vs. 9.6 +/- 1.1 nmol/liter X 180 min; P = 0.035). iGLP-1 was reduced in parallel to tGLP-1. Conclusions: 1) Release and degradation of the two incretin hormones show dissociated changes in obesity: GLP-1 but not GIP secretion is lower after meal ingestion and oral glucose, whereas GIP but not GLP-1 metabolism is increased after meal ingestion. 2) Increased plasma DPP-4 activity in obesity is not associated with a generalized augmented incretin hormone metabolism. (J Clin Endocrinol Metab 95: 872-878, 2010)